J.P. Morgan 35th Annual Healthcare Conference 2017
4 January 2017, Liverpool, UK – EnXray Ltd, will be attending the J.P. Morgan 35th Annual Healthcare Conference in San Francisco, USA and will be represented by its CEO, Ed Cappabianca and Chair of the Board, Renee Aguair-Lucander. If you wish to meet with either of them at the conference, please write to us at email@example.com or via this contact form.
We look forward to seeing you at the conference.
About EnXray Limited
EnXray Limited (EnXray) is a development-stage technology company founded in 2012, focused on commercializing its proprietary LEXR technology for use in sterilization. EnXray’s first target market is the medical device manufacturing industry, where our technology will enable companies to manage and control the sterilization of their products (the final critical step of their production process) on-site & on-demand, providing significant benefits to its customers.
Low Energy X-ray
Low Energy X-rays (LEXR), or “soft x-rays” are a form of ionizing radiation in the range of 5 – 20 keV, which have some compelling characteristics, including a short transmission range through air, combined with a high relative absorption coefficient, which makes it a very efficient method for delivering high dosages of radiation in a relatively short period of time, without the need for extensive shielding.